Sight Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Sight Sciences and other ETFs, options, and stocks.About SGHT
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments.
CEOPaul Badawi
CEOPaul Badawi
Employees216
Employees216
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2011
Founded2011
Employees216
Employees216
SGHT Key Statistics
Market cap417.69M
Market cap417.69M
Price-Earnings ratio-8.86
Price-Earnings ratio-8.86
Dividend yield—
Dividend yield—
Average volume342.49K
Average volume342.49K
High today$8.40
High today$8.40
Low today$7.74
Low today$7.74
Open price$7.98
Open price$7.98
Volume684.76K
Volume684.76K
52 Week high$9.24
52 Week high$9.24
52 Week low$2.03
52 Week low$2.03
Stock Snapshot
With a market cap of 417.69M, Sight Sciences(SGHT) trades at $7.93. The stock has a price-to-earnings ratio of -8.86.
On 2026-01-01, Sight Sciences(SGHT) stock traded between a low of $7.74 and a high of $8.40. Shares are currently priced at $7.93, which is +2.5% above the low and -5.6% below the high.
Sight Sciences(SGHT) shares are trading with a volume of 684.76K, against a daily average of 342.49K.
During the past year, Sight Sciences(SGHT) stock moved between $2.03 at its lowest and $9.24 at its peak.
During the past year, Sight Sciences(SGHT) stock moved between $2.03 at its lowest and $9.24 at its peak.
Analyst ratings
57%
of 7 ratingsBuy
42.9%
Hold
57.1%
Sell
0%
People also own
Based on the portfolios of people who own SGHT. This list is generated using Robinhood data, and it’s not a recommendation.